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Abstract: Sinonasal undifferentiated carcinoma (SNUC) is an aggressive malignancy 
originating in the mucosa lining the walls of the nasal cavity and paranasal sinuses. It is 
a rare tumor that usually presents in an advanced stage, is highly invasive, and is 
traditionally reputed to be refractory to even the most radical therapy with an attendant 
poor prognosis. This is particularly true when it transgresses the cranial base.  
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Introduction 
SNUC was first described in 1986 as a rare 
and highly aggressive neoplasm arising from 
the nasal cavity and paranasal sinuses[1]. 
These tumors tend to be large and expansile, 
with widespread involvement of the nasal 
cavity and paranasal sinuses. Bone destruction 
and invasion of adjacent structures such as the 
orbit, cranial vault, and skull base is frequently 
seen. The median age of presentation is the 
sixth decade and men are more commonly 
affected (male to female ratio of 2.3:1) The vast 
majority of affected patients present with 
epistaxis, rhinorrhea, nasal obstruction, and 
facial pain[2,3]. Very rarely these tumour 
present as Garcin syndrome. Garcin syndrome 
consists of unilateral palsies of almost all 
cranial nerves without either sensory or motor 
long-tract disturbances and without 
intracranial hypertension, and it is caused by a 
malignant osteoclastic lesion at the skull base. 
The underlying cause of Garcin’s syndrome is 
usually a sarcoma, lymphoma, metastasis, 
chemodectoma, or carcinoma of the skull base. 
The literature on Garcin’s syndrome is limited, 
and this makes the present case rare and 
interesting. The natural history, clinical course 
and histological features of SNUC are poorly 
understood[4] Overall survival of patients 
with SNUC is poor in most reported series. 
Although no clear consensus exists regarding 
treatment, a multidisciplinary approach 
combining surgery (craniofacial resection) 
with chemotherapy and radiation may be used 
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to control local disease[2,3]. The extent of 
disease at diagnosis represents the most 
sensitive predictor for survival. The purpose of 
this report is to present a case of SNUC and to 
review the current concepts of diagnosis, 
differential diagnosis and management of this 
rare disease. 
Case report  
43 years old patient presented to ous with 
complain of bifrontal headache and nasal 
obstruction from last 3 month. On 
examination patient was conscious and 
oriented to time place and person. His cranial 
nerve examination was normal except that 
there was decrease smell sensation on right 
side. Motor, sensory and cerebellar 
examination was normal and bladder bowel 
was not involved. Patient was investigated 
properly and MRI brain with contrast was 
done [figure 1, figures 2A and 2B]. Patient was 
planned for surgery and right sided extended 
frontal craniotomy was done. Tumour present 
in basifrontal ethmoidal region was removed, 
part of tumour attached to medial wall of orbit 
was left [Figure 3]. Dura was repaired and 
frontal sinus was exteriorized. Postoperatively 
patient was conscious and oriented. On day 5 
patient develop headache and on subsequent 
days right sided ptosis was noticed. Initially it 
was partial ptosis but in 2-3 days it become 
complete ptosis and it also develop on 
contralateral side. On examination we found 
that there is also involvement of 4th and 6th 
cranial nerve. Within next 5-6 days there is 
also involvement of 5th, 7th, 9th, 10th and 
12th cranial nerve on ipsilateral side. Patient 
also develop pain in the back region. Inspite of 
involvement of multiple cranial nerve patient 
had no motor and sensory impairment and his 
bladder and bowel was intact. 
We report this case as SNUC is very very 
rare and involvement of multiple cranial nerve 
in step by step fashion without impairment of 
motor and sensory systems (Garcin 
syndrome) is extremely rare. So this case 
become an interesting case and only few such 
cases are reported in the literature.  
 
A B C 
Figure 1A - MRI T1W axial image shows 
hypointence mass present in right frontal region 
 Figure 1B - MRI T2W axial image shows iso to 
hypointence mass present in right frontal region 
 Figure 1C - Contrast MRI axial image shows contrast 
enhancing mass present in right frontal region 
 
A B C 
Figure 2A - Contrast MRI  saggital  image  shows 
contrast enhancing mass in right basifrontal region with 
extension into nasal cavity   
Figure 2B - Contrast MRI coronal image image shows 
contrast enhancing mass in right basifrontal region with 
extension into paranasal sinuses   
 Figure 2C - H&E stained sections show a tumour 
disposed in nests with interspersed lymphocytes and 
plasma cells. The tumourcells are round to oval with high 
nuclei-cytoplasmic ratio, hyperchromatic nuclei and scant 
cytoplasm. Numerous mitotic figuresare evident 
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A B C 
Figure 3A - Post ope MRI T1W axial image  shows 
hyperintence changes in right frontal region 
 Figure 3B - Post ope MRI T2W axial image  shows iso to  
hyperintence  changes   in right frontal region 
 Figure 3C - Post ope contrast MRI axial image  shows  
small residual tumour in right frontal region 
Discussion  
SNUC is an aggressive, highly malignant 
tumor of the mucosal lining of the nasal and 
paranasal sinuses. It was first described as a 
distinct and separate entity by Frierson et al in 
1986 [5].The prognosis of the patient is very 
poor with high frequency of local recurrence 
and distant metastasis. These tumour 
generally present with epistaxis, nasal 
obstruction and headache. Very rarely these 
tumour present as Garcin syndrome. Garcin 
syndrome is an ipsilateral step-by-step 
deterioration of all 12 cranial nerves, first 
described in 1927. This rare progressive 
condition is generally associated with skull 
based malignant osteoclastic lesions but has 
also been described with sarcoma, lymphoma, 
metastasis, chemodectoma, or carcinoma of 
the skull base. 
Cranial nerves involvement in these 
tumour occurs in many ways. First, the tumor 
may extend superiorly through foramen 
lacerum, which is an unimpeded pathway near 
the fossa of Rosenmuller into the cranium, 
thus involving the cranial nerves in the middle 
cranial fossa and cavernous sinus. Cancer may 
break through the pharyngo-basilar fascia and 
spread along vascular sheaths, that is, facial 
planes surrounding the jugular vein and 
carotid artery. Lateral and posterior extension 
of the primary growth itself may involve the 
lower cranial nerves exiting from jugular and 
hypoglossal foramina. 
Confirming the diagnosis of SNUC at the 
light microscopic level can be challenging, 
since the microscopic differential diagnosis 
include olfactory neuroblastoma, 
rhabdomyosarcoma, undifferentiated 
nasopharyngeal carcinoma 
(lymphoepithelioma), malignant lymphoma, 
malignant melanoma and neuroendocrine 
carcinoma. SNUC can be differentiated from 
these other neoplasm by correlating clinical, 
light microscopic, immunohistochemical and 
ultrastructural charecteristics. [6] The tumour 
is positive for pan-cytokeratin, epithelial 
membrane antigen, CD99, cytokeratin7 with 
scattered p-40 expression on 
immunohistochemistry. 
Olfactory neuroblastoma typically present 
as a polypoidal mass protruding from the roof 
of nasal cavity. Immunohistochemistry 
demonstrate staining for neuroendocrine 
markers such as neuron specific enolase 
(NSE), synaptophysin and chromogranin. S-
100 is usually positive in a sustentacular 
pattern [7]. 
Differential diagnosis of SNUC from 
olfactory neuroblastoma and neuroendocrine 
carcinoma may be difficult because a small 
proportion of SNUC may express 
neuroendocrine markers including NSE and 
 
 
 
 
 
Romanian Neurosurgery (2017) XXXI 4: 564 - 567 | 567 
 
 
 
 
 
 
 
chromogranin. However SNUC lacks S-100 
and does not show glandular differentiation or 
rosettes. SNUC has more extensive cytological 
atypia and necrosis. Ultrastructurally 
neuroendocrine markers tend to be focal and 
no neurosecretory granules are evident in 
SNUC. [8] Melanoma and lymphoma are 
easily differentiated on the basis of 
immunohistochemistry. Melanoma stain 
positively for S-100, HMB 45 and melan A, 
while lymphomas are invariably positive for 
CD19 and CD20 as well as other B cell lineage 
markers [9]. 
Due to rarity of the disease the proper 
diagnostic and management criteria could not 
be defined. On reviewing the literature we 
found that we can differentiate this tumour 
from others by histological and 
immunohistochemical properties. SNUC 
could be treated by craniofacial resection 
followed by adjuvant radiotherapy and or 
combination of chemotherapy. Inspite of these 
multimodality treatment these tumour recur 
in one year and most of these patient died. 
[10]. So early diagnosis and prompt treatment 
can improve the survival of these patient. 
Conclusion 
Sinonasal undifferentiated carcinomas 
(SNUC) are highly aggressive lesions arising in 
the superior nasal cavity and paranasal sinuses. 
The differential diagnosis may be wide since a 
range of similar lesions may present at this site. 
Recently the criteria for diagnosis of SNUC has 
been clarified. On the basis of histological and 
immunohistochemical charecteristics we can 
differentiate it from other lesions. 
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